Get started
JetEquities

Heron Announces Positive Topline Results from Phase 3b Clinical

Long
Heron Therapeutics, Inc. (NASDAQ:HRTX)  
JetEquities  
NASDAQ:HRTX   Heron Therapeutics, Inc.
Beyond Technical Analysis
2
1
beyondta
HRTX: Heron Therapeutics, Inc.
2019-10-02 07:45:00
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.